Click for best price
Nasal Polyps Drugs Market Size, Share 2022
Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occur in both nostrils in those who are affected. Complications may include sinusitis and broadening of the nose.
This report contains market size and forecasts of Nasal Polyps Drugs in Global, including the following market information:
Global top five companies in 2021 (%)
The global Nasal Polyps Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nasal Polyps Drugs include Pfizer, Roche, Sanofi, Novartis, GlaxoSmithKline, Merck and Regeneron Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nasal Polyps Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nasal Polyps Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nasal Polyps Drugs Market Segment Percentages, by Type, 2021 (%)
- Corticosteroids
- Antibiotics
- Leukotriene Inhibitors
- Others
Global Nasal Polyps Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nasal Polyps Drugs Market Segment Percentages, by Application, 2021 (%)
Global Nasal Polyps Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nasal Polyps Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Nasal Polyps Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Nasal Polyps Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Roche
- Sanofi
- Novartis
- GlaxoSmithKline
- Merck
- Regeneron Pharmaceuticals
| Report Attributes |
Report Details |
| Report Title |
Nasal Polyps Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nasal Polyps Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nasal Polyps Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nasal Polyps Drugs Overall Market Size
2.1 Global Nasal Polyps Drugs Market Size: 2021 VS 2028
2.2 Global Nasal Polyps Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nasal Polyps Drugs Players in Global Market
3.2 Top Global Nasal Polyps Drugs Companies Ranked by Revenue
3.3 Global Nasal Polyps Drugs Revenue by Companies
3.4 Top 3 and Top 5 Nasal Polyps Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Nasal Polyps Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nasal Polyps Drugs Players in Global Market
3.6.1 List of Global Tier 1 Nasal Polyps Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Nasal Polyps Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Nasal Polyps Drugs Market Size Markets, 2021 & 2028
4.1.2 Corticosteroids
4.1.3 Antibiotics
4.1.4 Leukotriene Inhibitors
4.1.5 Others
4.2 By Type - Global Nasal Polyps Drugs Revenue & Forecasts
4.2.1 By Type - Global Nasal Polyps Drugs Revenue, 2017-2022
4.2.2 By Type - Global Nasal Polyps Drugs Revenue, 2023-2028
4.2.3 By Type - Global Nasal Polyps Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nasal Polyps Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Nasal Polyps Drugs Revenue & Forecasts
5.2.1 By Application - Global Nasal Polyps Drugs Revenue, 2017-2022
5.2.2 By Application - Global Nasal Polyps Drugs Revenue, 2023-2028
5.2.3 By Application - Global Nasal Polyps Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Nasal Polyps Drugs Market Size, 2021 & 2028
6.2 By Region - Global Nasal Polyps Drugs Revenue & Forecasts
6.2.1 By Region - Global Nasal Polyps Drugs Revenue, 2017-2022
6.2.2 By Region - Global Nasal Polyps Drugs Revenue, 2023-2028
6.2.3 By Region - Global Nasal Polyps Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Nasal Polyps Drugs Revenue, 2017-2028
6.3.2 US Nasal Polyps Drugs Market Size, 2017-2028
6.3.3 Canada Nasal Polyps Drugs Market Size, 2017-2028
6.3.4 Mexico Nasal Polyps Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Nasal Polyps Drugs Revenue, 2017-2028
6.4.2 Germany Nasal Polyps Drugs Market Size, 2017-2028
6.4.3 France Nasal Polyps Drugs Market Size, 2017-2028
6.4.4 U.K. Nasal Polyps Drugs Market Size, 2017-2028
6.4.5 Italy Nasal Polyps Drugs Market Size, 2017-2028
6.4.6 Russia Nasal Polyps Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Nasal Polyps Drugs Market Size, 2017-2028
6.4.8 Benelux Nasal Polyps Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Nasal Polyps Drugs Revenue, 2017-2028
6.5.2 China Nasal Polyps Drugs Market Size, 2017-2028
6.5.3 Japan Nasal Polyps Drugs Market Size, 2017-2028
6.5.4 South Korea Nasal Polyps Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Nasal Polyps Drugs Market Size, 2017-2028
6.5.6 India Nasal Polyps Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Nasal Polyps Drugs Revenue, 2017-2028
6.6.2 Brazil Nasal Polyps Drugs Market Size, 2017-2028
6.6.3 Argentina Nasal Polyps Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nasal Polyps Drugs Revenue, 2017-2028
6.7.2 Turkey Nasal Polyps Drugs Market Size, 2017-2028
6.7.3 Israel Nasal Polyps Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Nasal Polyps Drugs Market Size, 2017-2028
6.7.5 UAE Nasal Polyps Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Nasal Polyps Drugs Major Product Offerings
7.1.4 Pfizer Nasal Polyps Drugs Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Nasal Polyps Drugs Major Product Offerings
7.2.4 Roche Nasal Polyps Drugs Revenue in Global Market (2017-2022)
7.2.5 Roche Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Nasal Polyps Drugs Major Product Offerings
7.3.4 Sanofi Nasal Polyps Drugs Revenue in Global Market (2017-2022)
7.3.5 Sanofi Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Nasal Polyps Drugs Major Product Offerings
7.4.4 Novartis Nasal Polyps Drugs Revenue in Global Market (2017-2022)
7.4.5 Novartis Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Nasal Polyps Drugs Major Product Offerings
7.5.4 GlaxoSmithKline Nasal Polyps Drugs Revenue in Global Market (2017-2022)
7.5.5 GlaxoSmithKline Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Nasal Polyps Drugs Major Product Offerings
7.6.4 Merck Nasal Polyps Drugs Revenue in Global Market (2017-2022)
7.6.5 Merck Key News
7.7 Regeneron Pharmaceuticals
7.7.1 Regeneron Pharmaceuticals Corporate Summary
7.7.2 Regeneron Pharmaceuticals Business Overview
7.7.3 Regeneron Pharmaceuticals Nasal Polyps Drugs Major Product Offerings
7.7.4 Regeneron Pharmaceuticals Nasal Polyps Drugs Revenue in Global Market (2017-2022)
7.7.5 Regeneron Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nasal Polyps Drugs Market Opportunities & Trends in Global Market
Table 2. Nasal Polyps Drugs Market Drivers in Global Market
Table 3. Nasal Polyps Drugs Market Restraints in Global Market
Table 4. Key Players of Nasal Polyps Drugs in Global Market
Table 5. Top Nasal Polyps Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Nasal Polyps Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Nasal Polyps Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Nasal Polyps Drugs Product Type
Table 9. List of Global Tier 1 Nasal Polyps Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nasal Polyps Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Nasal Polyps Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Nasal Polyps Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Nasal Polyps Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Nasal Polyps Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Nasal Polyps Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Nasal Polyps Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Nasal Polyps Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Nasal Polyps Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Nasal Polyps Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Nasal Polyps Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Nasal Polyps Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Nasal Polyps Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Nasal Polyps Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Nasal Polyps Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Nasal Polyps Drugs Product Offerings
Table 32. Pfizer Nasal Polyps Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Nasal Polyps Drugs Product Offerings
Table 35. Roche Nasal Polyps Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Nasal Polyps Drugs Product Offerings
Table 38. Sanofi Nasal Polyps Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Nasal Polyps Drugs Product Offerings
Table 41. Novartis Nasal Polyps Drugs Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Nasal Polyps Drugs Product Offerings
Table 44. GlaxoSmithKline Nasal Polyps Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Nasal Polyps Drugs Product Offerings
Table 47. Merck Nasal Polyps Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Regeneron Pharmaceuticals Corporate Summary
Table 49. Regeneron Pharmaceuticals Nasal Polyps Drugs Product Offerings
Table 50. Regeneron Pharmaceuticals Nasal Polyps Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Nasal Polyps Drugs Segment by Type in 2021
Figure 2. Nasal Polyps Drugs Segment by Application in 2021
Figure 3. Global Nasal Polyps Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nasal Polyps Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nasal Polyps Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nasal Polyps Drugs Revenue in 2021
Figure 8. By Type - Global Nasal Polyps Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Nasal Polyps Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Nasal Polyps Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Nasal Polyps Drugs Revenue Market Share, 2017-2028
Figure 12. US Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Nasal Polyps Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Nasal Polyps Drugs Revenue Market Share, 2017-2028
Figure 24. China Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Nasal Polyps Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Nasal Polyps Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Nasal Polyps Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Nasal Polyps Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Nasal Polyps Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Nasal Polyps Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Nasal Polyps Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Nasal Polyps Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Nasal Polyps Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Regeneron Pharmaceuticals Nasal Polyps Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
